Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary
Jubilant Pharmova Ltd Q4FY25; 10% rise in Revenue
Categories
contract research
Syngene International Ltd Q4FY25; 3% fall in Profits
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated
Syngene International Ltd Q3FY25; 17% rise in Profits
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated
Jubilant Pharmova Ltd Q3FY25; 53% rise in Profits
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary
Jubilant Pharmova Ltd Q2FY25; 65% rise in Profits
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary
Piramal Pharma Ltd Q2FY25; 360% rise in Profits
Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments (1) Contract development
Syngene International Ltd Q2FY25; 9% fall in Profits
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated
Shilpa Medicare Ltd Q1FY24; 50% fall in Profits
Shilpa Medicare Incorporated in 1987 manufactures niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service for some of
Pfizer Ltd Q1FY25; 61% rise in Profits
Pfizer Ltd is engaged in manufacturing, marketing, trading and export of pharmaceutical products. It manufactures products through its own facility and also
Piramal Pharma Ltd Q1FY25; 12% rise in Revenue
Piramal Pharma Limited (PPL) is part of the Piramal group of companies. The company operates through 3 major segments(1) Contract development and
Syngene International Ltd Q1FY25; 18% fall in Profits
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated
Syngene International Ltd Q4FY24; 6% rise in Profits
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated
Jubilant Pharmova Ltd Q4FY24; 5% rise in Revenue
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary
Shilpa Medicare Ltd Q4FY24; 11% rise in Revenue
Shilpa Medicare Incorporated in 1987 manufactures niche APIs, intermediates, and formulations and also undertakes contract research and manufacturing service for some of
Sun Pharma Advanced Research Company Ltd Q3FY24; 89% fall in Revenue
Sun Pharma Advanced Research Company Ltd is engaged in the business of research and development (R&D) of pharmaceutical products. Financial Results: Sun
Tarsons Products Ltd Q3FY24; 38% fall in Profits
Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others'
Jubilant Pharmova Ltd Q3FY24; 8% rise in Revenue
Jubilant Pharmova Ltd is an integrated global pharmaceuticals company having three business segments i.e. pharmaceuticals, contract research and development services and proprietary
Syngene International Ltd Q3FY24; 2% rise in Profits
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated
Tarsons Products Ltd Q2FY24; 38% fall in Profits
Tarsons Products Ltd. (TPL) is an Indian labware company engaged in the designing, development, manufacturing, and marketing of 'consumables', 'reusables' and 'others'
Syngene International Ltd Q2FY24; 14% rise in Profits
Syngene (established in 1993) as a Biocon subsidiary is India's first Contract Research Organization (CRO) which expanded later to be an integrated
Vimta Labs Ltd Q1FY24; 4% rise in Revenue
Vimta Labs Limited is testing food and drugs. It also does contract research for clinical research and pre-clinical studies provider in India.